172 related articles for article (PubMed ID: 20471975)
1. Expression of leukemia/lymphoma-related factor (LRF/POKEMON) in human breast carcinoma and other cancers.
Aggarwal A; Hunter WJ; Aggarwal H; Silva ED; Davey MS; Murphy RF; Agrawal DK
Exp Mol Pathol; 2010 Oct; 89(2):140-8. PubMed ID: 20471975
[TBL] [Abstract][Full Text] [Related]
2. Expression of leukemia/lymphoma related factor (LRF/Pokemon) in human benign prostate hyperplasia and prostate cancer.
Aggarwal H; Aggarwal A; Hunter WJ; Yohannes P; Khan AU; Agrawal DK
Exp Mol Pathol; 2011 Apr; 90(2):226-30. PubMed ID: 21251909
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor increases LRF/Pokemon expression in human prostate cancer cells.
Aggarwal H; Aggarwal A; Agrawal DK
Exp Mol Pathol; 2011 Oct; 91(2):496-501. PubMed ID: 21640721
[TBL] [Abstract][Full Text] [Related]
4. Role of LRF/Pokemon in lineage fate decisions.
Lunardi A; Guarnerio J; Wang G; Maeda T; Pandolfi PP
Blood; 2013 Apr; 121(15):2845-53. PubMed ID: 23396304
[TBL] [Abstract][Full Text] [Related]
5. Utility of LRF/Pokemon and NOTCH1 protein expression in the distinction between nodular lymphocyte-predominant Hodgkin lymphoma and classical Hodgkin lymphoma.
Bohn O; Maeda T; Filatov A; Lunardi A; Pandolfi PP; Teruya-Feldstein J
Int J Surg Pathol; 2014 Feb; 22(1):6-11. PubMed ID: 24326827
[TBL] [Abstract][Full Text] [Related]
6. The transcription factor FBI-1/OCZF/LRF is expressed in osteoclasts and regulates RANKL-induced osteoclast formation in vitro and in vivo.
Kukita A; Kukita T; Nagata K; Teramachi J; Li YJ; Yoshida H; Miyamoto H; Gay S; Pessler F; Shobuike T
Arthritis Rheum; 2011 Sep; 63(9):2744-54. PubMed ID: 21590684
[TBL] [Abstract][Full Text] [Related]
7. Expression of the proto-oncogene Pokemon in colorectal cancer--inhibitory effects of an siRNA.
Zhao GT; Yang LJ; Li XX; Cui HL; Guo R
Asian Pac J Cancer Prev; 2013; 14(9):4999-5005. PubMed ID: 24175766
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of Leukemia/Lymphoma-Related Factor Protein Expression Inhibits Glioma Cell Proliferation and Invasion.
Huang R; Xie T; Zhao Y; Yao CS
J Environ Pathol Toxicol Oncol; 2015; 34(2):125-31. PubMed ID: 26081031
[TBL] [Abstract][Full Text] [Related]
9. Stage-specific functions of leukemia/lymphoma-related factor (LRF) in the transcriptional control of osteoclast development.
Tsuji-Takechi K; Negishi-Koga T; Sumiya E; Kukita A; Kato S; Maeda T; Pandolfi PP; Moriyama K; Takayanagi H
Proc Natl Acad Sci U S A; 2012 Feb; 109(7):2561-6. PubMed ID: 22308398
[TBL] [Abstract][Full Text] [Related]
10. Leukemia/lymphoma-related factor regulates oligodendrocyte lineage cell differentiation in developing white matter.
Dobson NR; Moore RT; Tobin JE; Armstrong RC
Glia; 2012 Sep; 60(9):1378-90. PubMed ID: 22615173
[TBL] [Abstract][Full Text] [Related]
11. LRF maintains genome integrity by regulating the non-homologous end joining pathway of DNA repair.
Liu XS; Chandramouly G; Rass E; Guan Y; Wang G; Hobbs RM; Rajendran A; Xie A; Shah JV; Davis AJ; Scully R; Lunardi A; Pandolfi PP
Nat Commun; 2015 Oct; 6():8325. PubMed ID: 26446488
[TBL] [Abstract][Full Text] [Related]
12. The oncogene LRF is a survival factor in chondrosarcoma and contributes to tumor malignancy and drug resistance.
Kumari R; Li H; Haudenschild DR; Fierro F; Carlson CS; Overn P; Gupta L; Gupta K; Nolta J; Yik JH; Di Cesare PE
Carcinogenesis; 2012 Nov; 33(11):2076-83. PubMed ID: 22847180
[TBL] [Abstract][Full Text] [Related]
13. LRF inhibits p53 expression in colon cancer cells via modulating DAP5 activity.
Zhu M; Wang P; Feng F; Li MY
Cell Biochem Funct; 2017 Oct; 35(7):401-406. PubMed ID: 28849590
[TBL] [Abstract][Full Text] [Related]
14. Expression of the nuclear coactivator AIB1 in normal and malignant breast tissue.
List HJ; Reiter R; Singh B; Wellstein A; Riegel AT
Breast Cancer Res Treat; 2001 Jul; 68(1):21-8. PubMed ID: 11678305
[TBL] [Abstract][Full Text] [Related]
15. Increase of GKLF messenger RNA and protein expression during progression of breast cancer.
Foster KW; Frost AR; McKie-Bell P; Lin CY; Engler JA; Grizzle WE; Ruppert JM
Cancer Res; 2000 Nov; 60(22):6488-95. PubMed ID: 11103818
[TBL] [Abstract][Full Text] [Related]
16. MeCP2 and MBD2 expression during normal and pathological growth of the human mammary gland.
Billard LM; Magdinier F; Lenoir GM; Frappart L; Dante R
Oncogene; 2002 Apr; 21(17):2704-12. PubMed ID: 11965543
[TBL] [Abstract][Full Text] [Related]
17. Loss of the tumor suppressor PML in human cancers of multiple histologic origins.
Gurrieri C; Capodieci P; Bernardi R; Scaglioni PP; Nafa K; Rush LJ; Verbel DA; Cordon-Cardo C; Pandolfi PP
J Natl Cancer Inst; 2004 Feb; 96(4):269-79. PubMed ID: 14970276
[TBL] [Abstract][Full Text] [Related]
18. Leukemia/lymphoma-related factor (LRF) exhibits stage- and context-dependent transcriptional controls in the oligodendrocyte lineage and modulates remyelination.
Davidson NL; Yu F; Kijpaisalratana N; Le TQ; Beer LA; Radomski KL; Armstrong RC
J Neurosci Res; 2017 Dec; 95(12):2391-2408. PubMed ID: 28556945
[TBL] [Abstract][Full Text] [Related]
19. Relaxin-like factor (RLF) is differentially expressed in the normal and neoplastic human mammary gland.
Hombach-Klonisch S; Buchmann J; Sarun S; Fischer B; Klonisch T
Cancer; 2000 Dec; 89(11):2161-8. PubMed ID: 11147585
[TBL] [Abstract][Full Text] [Related]
20. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma.
Elloul S; Elstrand MB; Nesland JM; Tropé CG; Kvalheim G; Goldberg I; Reich R; Davidson B
Cancer; 2005 Apr; 103(8):1631-43. PubMed ID: 15742334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
